Oncolytics Biotech News

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

19.09.24	Oncolytics Biotech Reports Favorable Results For Breast Cancer Study (RTTNews)
24.06.24	Oncolytics Biotech Names Wayne Pisano Interim CEO - Quick Facts (RTTNews)
09.11.23	Oncolytics Announced Positive Interim Results From Phase 1/2 GOBLET Study In Anal Cancer (RTTNews)
26.09.23	THE PANCREATIC CANCER ACTION NETWORK SELECTS ONCOLYTICS BIOTECH® INC. TO RECEIVE $5 MILLION THERAPEUTIC ACCELERATOR AWARD TO DEVELOP LEADING-EDGE TREATMENTS (PR Newswire)
08.12.22	Oncolytics' Chinese Partner Adlai Nortye Reports Interim Results Of Pelareorep-paclitaxel (RTTNews)
07.11.22	Oncolytics: Interim Results From Phase 1/2 GOBLET Study Shows 70% Objective Response Rate (RTTNews)
28.06.22	Oncolytics' GOBLET Study Meets Efficacy Expansion Criteria In Pancreatic Cancer Cohort (RTTNews)
15.12.21	Oncolytics : Data Shows Synergistic Anti-Leukemic Effects Of Pelareorep Combined With Azacitidine (RTTNews)
26.11.21	Pre-market Movers: ISPC, AHPI, APT, BIMI, VALN… (RTTNews)
20.09.21	Oncolytics : Preclinical Data Shows Synergistic Immunotherapeutic Effects Of Pelareorep-Radiotherapy (RTTNews)
06.08.21	Oncolytics Biotech® Reports 2021 Second Quarter Development Highlights and Financial Results (PR Newswire)
06.08.21	Oncolytics Biotech® Reports 2021 Second Quarter Development Highlights and Financial Results (PR Newswire)
06.08.21	Oncolytics Biotech® Reports 2021 Second Quarter Development Highlights and Financial Results (PR Newswire)
06.08.21	Oncolytics Biotech® to Participate in Virtual Fireside Chat at the Canaccord Genuity 41st Annual Growth Conference (PR Newswire)
06.08.21	Oncolytics Biotech® to Participate in Virtual Fireside Chat at the Canaccord Genuity 41st Annual Growth Conference (PR Newswire)
06.08.21	Oncolytics Biotech® to Participate in Virtual Fireside Chat at the Canaccord Genuity 41st Annual Growth Conference (PR Newswire)
22.07.21	Oncolytics Biotech® to Host Conference Call to Discuss Second Quarter Financial Results and Operational Highlights (PR Newswire)
22.07.21	Oncolytics Biotech® to Host Conference Call to Discuss Second Quarter Financial Results and Operational Highlights (PR Newswire)
22.07.21	Oncolytics Biotech® to Host Conference Call to Discuss Second Quarter Financial Results and Operational Highlights (PR Newswire)
30.06.21	Oncolytics Biotech® to Present at the Ladenburg Thalmann Healthcare Conference (PR Newswire)
30.06.21	Oncolytics Biotech® to Present at the Ladenburg Thalmann Healthcare Conference (PR Newswire)
30.06.21	Oncolytics Biotech® to Present at the Ladenburg Thalmann Healthcare Conference (PR Newswire)
20.05.21	Oncolytics Biotech® Announces Clinical and Biomarker Data Demonstrating Clinical Proof-of-Concept for Pelareorep-Checkpoint Inhibitor Combination in Pancreatic Cancer (PR Newswire)
20.05.21	Oncolytics Biotech® Announces Clinical and Biomarker Data Demonstrating Clinical Proof-of-Concept for Pelareorep-Checkpoint Inhibitor Combination in Pancreatic Cancer (PR Newswire)
20.05.21	Oncolytics Biotech® Announces Clinical and Biomarker Data Demonstrating Clinical Proof-of-Concept for Pelareorep-Checkpoint Inhibitor Combination in Pancreatic Cancer (PR Newswire)
13.05.21	Oncolytics Biotech® to Participate in Virtual Fireside Chat at the 2021 RBC Capital Markets Global Healthcare Conference (PR Newswire)
13.05.21	Oncolytics Biotech® to Participate in Virtual Fireside Chat at the 2021 RBC Capital Markets Global Healthcare Conference (PR Newswire)
13.05.21	Oncolytics Biotech® to Participate in Virtual Fireside Chat at the 2021 RBC Capital Markets Global Healthcare Conference (PR Newswire)
10.05.21	Oncolytics Biotech® Announces Voting Results from the Annual General Meeting of Shareholders (PR Newswire)
10.05.21	Oncolytics Biotech® Announces Voting Results from the Annual General Meeting of Shareholders (PR Newswire)
10.05.21	Oncolytics Biotech® Announces Voting Results from the Annual General Meeting of Shareholders (PR Newswire)
07.05.21	Oncolytics Biotech® Reports 2021 First Quarter Development Highlights and Financial Results (PR Newswire)
07.05.21	Oncolytics Biotech® Reports 2021 First Quarter Development Highlights and Financial Results (PR Newswire)
07.05.21	Oncolytics Biotech® Reports 2021 First Quarter Development Highlights and Financial Results (PR Newswire)
30.04.21	Oncolytics Biotech® Announces Annual General Meeting (PR Newswire)
30.04.21	Oncolytics Biotech® Announces Annual General Meeting (PR Newswire)
30.04.21	Oncolytics Biotech® Announces Annual General Meeting (PR Newswire)
29.04.21	Oncolytics Biotech® Announces Upcoming Presentation at the American Society of Clinical Oncology Annual Meeting (PR Newswire)
29.04.21	Oncolytics Biotech® Announces Upcoming Presentation at the American Society of Clinical Oncology Annual Meeting (PR Newswire)
29.04.21	Oncolytics Biotech® Announces Upcoming Presentation at the American Society of Clinical Oncology Annual Meeting (PR Newswire)
12.04.21	Oncolytics Biotech® and SOLTI Achieve Primary Endpoint in AWARE-1 Study (PR Newswire)
12.04.21	Oncolytics Biotech® and SOLTI Achieve Primary Endpoint in AWARE-1 Study (PR Newswire)
12.04.21	Oncolytics Biotech® and SOLTI Achieve Primary Endpoint in AWARE-1 Study (PR Newswire)
12.04.21	Oncolytics Biotech® Presents Preclinical Data on Pelareorep-based Combination Therapies at the AACR Annual Meeting (PR Newswire)
12.04.21	Oncolytics Biotech® Presents Preclinical Data on Pelareorep-based Combination Therapies at the AACR Annual Meeting (PR Newswire)
12.04.21	Oncolytics Biotech® Presents Preclinical Data on Pelareorep-based Combination Therapies at the AACR Annual Meeting (PR Newswire)
08.04.21	Oncolytics Biotech® to Participate in a Panel Discussion at the Canaccord Genuity Horizons in Oncology Virtual Conference (PR Newswire)
08.04.21	Oncolytics Biotech® to Participate in a Panel Discussion at the Canaccord Genuity Horizons in Oncology Virtual Conference (PR Newswire)
08.04.21	Oncolytics Biotech® to Participate in a Panel Discussion at the Canaccord Genuity Horizons in Oncology Virtual Conference (PR Newswire)
05.04.21	Oncolytics Biotech® to Host Key Opinion Leader Webinar to Discuss AWARE-1 Data, the Immunotherapeutic Effects of Pelareorep in Breast Cancer, and its Synergistic Activity with CAR T Cells in Solid... (PR Newswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Logitech Intl	82.44	3.18 %	K V
Kuehne+Nagel Int	207.20	1.27 %	K V
Swisscom	508.00	0.30 %	K V
Novartis	89.97	0.27 %	K V
Roche Hldg G	274.50	0.26 %	K V
UBS Group	31.50	-0.25 %	K V
Zurich Insur Gr	536.20	-0.30 %	K V
Alcon	80.62	-0.35 %	K V
ABB	53.30	-0.49 %	K V
Sonova Hldg	315.50	-0.94 %	K V

Nachrichten zu Oncolytics Biotech Inc Registered Shs

Aktien Top/Flop

Meistgelesene Nachrichten